Top Back to top

Transplant Complications Working Party (TCWP)

The aim of the Transplant Complications Working Party is to conduct research as well as provide education and expertise on the subject of non-infectious complications after hematopoietic cell transplantation. The major fields of interest of the TCWP are:

  • Early complications e.g. graft failure, VOD/SOS, transplant-associated microangiopathy (TAM), other endothelial syndromes, impact of co-morbidities, toxicity of conditioning regimen and supportive care;
  • Acute and chronic graft versus host disease – all the aspects from risk factors through diagnosis to treatment;
  • Late effects – e.g. infertility, sexual dysfunction, secondary cancers, organ-specific late complications, quality of life.

The TCWP is a transversal Working Party, covering complications occurring after transplantation for all the indications. Therefore, its performance is strictly related to collaboration with disease-specific working parties, and studies directly dedicated to non-infectious complications should be performed either in or in close collaboration with TCWP. 


To submit a proposal to the TCWP for a new study, download the following documents:

Open calls to participate in a new study

The Transplant Complications Working Party is currently overseeing the following studies. 

SFAST: A cross-sectional study on the sexual function of adult survivors and their partners 3 and 15 years post allogeneic stem cell transplantation

PI: Corien Eeltink

Complications of haploidentical HCT with post-transplant cyclophosphamide - a non-interventional prospective study

PI: Grzegorz Basak

NIS: EASIX to predict alloSCT outcome

PIs: Olaf Penack and Thomas Luft

Fecal microbiota transplantation in the treatment of graft-versus-host disease – retrospective survey

PI: Jarosław Biliński

Current practice in vitamin D assessment and management across the Adult and Paediatric Haematopoietic Stem Cell Transplant Centres in Europe (SUNSHINE).

 PI: Jose Ros-Soto

Late effects after hematopoietic stem cell transplantation in patients with HLH.

PI: Anna Carin-Horne


Subcommittees & Members

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to